The tau A0 allele in Parkinson's disease

Movement Disorders

Volumn 16, Issue 3, 2001, Pages 442-447

  Golbe, Lawrence I ^a   Lazzarini, Alice M ^a   Spychala, John R ^a   Johnson, William G ^a   Stenroos, Edward S ^a   Mark, Margery H ^a   Sage, Jacob I ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Genetics; Parkinson's disease; Progressive supranuclear palsy; Tau

Indexed keywords

LEVODOPA; TAU PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; BLOOD ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ERROR; DINUCLEOTIDE REPEAT; FAMILIAL DISEASE; FEMALE; GENE FREQUENCY; GENETIC SCREENING; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE; TAUOPATHY;

AGED; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; PARKINSON DISEASE; PROTEIN ISOFORMS; SUPRANUCLEAR PALSY, PROGRESSIVE; SYNUCLEINS; TAU PROTEINS;

EID: 0035353746     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.1087     Document Type: Article

References (22)

1. Brandt R, Lee G. Functional organization of microtubule-associated protein tau. J Biol Chem 1993;268:3414-3419.
2. Goedert M, Jakes R, Crowther RA, et al. The abnormal phosphorylation of tau protein at Ser202 in Alzheimer disease recapitulates phosphorylation during development. Proc Natl Acad Sci USA 1993;90:5066-5070.
3. Mailliot C, Sergeant N, Bussiere T, Caillet-Boudin ML, Delacourte A, Buee L. Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes. FEBS Lett 1998; 433:201-204.
4. Lilius L, Froelich-Fabre S, Basun H, et al. Tau gene polymorphisms and apolipoprotein E epsilon4 may interact to increase risk for Alzheimer's disease. Neurosci Lett 1999;277:29-32.
5. Conrad C, Andreadis A, Trojanowski JQ, et al. Genetic evidence for the involvement of τ in progressive supranuclear palsy. Ann Neurol 1997;41:277-281.
6. Higgins JJ, Adler RL, Loveless JM. Mutational analysis of the tau gene in progressive supranuclear palsy. Neurology 1999;53:1421-1424.
7. Baker M, Litvan I, Houlden H, et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 1999;8:711-715.
8. Spillantini MG, Schmidt ML, Lee V-Y, Trojanowski JQ, Jakes R, Goedert M. α-synuclein in Lewy bodies. Nature 1997;388:839-840.
9. Arima K, Hirai S, Sunohara N, et al. Cellular co-localization of phosphorylated tau- and NACP/α-synuclein-epitopes in Lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies. Brain Res 1999;843:53-61.
10. Jensen PH, Hager H, Nielsen MS, Hojrup P, Gliemann J, Jakes R. α-synuclein binds to tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356. J Biol Chem 1999;274:25481-25489.
11. Mori H, Kondo T, Yokochi M, et al. Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neurology 1998;51:890-892.
12. Lazzarini AM, Golbe LI, Dickson DW, Duvoisin RC, Johnson WG. Tau intronic polymorphism in Parkinson's disease and progressive supranuclear palsy. Neurology 1997;48:A427 (abstract).
13. Hoenicka J, Pérez M, Pérez-Tur J, et al. The tau gene A0 allele and progressive supranuclear palsy. Neurology 1999;53:1219-1225.
14. Morris HR, Janssen JC, Bandmann O, Daniel SE, Rossor MN, Lees AJ, Wood NW. The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases. J Neurol Neurosurg Psychiatry 1999;66:665-667.
15. Pastor P, Ezquerra M, Muñoz E, Martí MJ, Blesa R, Tolosa E, Oliva R. Significant association between the tau gene A0/A0 genotype and Parkinson's disease. Ann Neurol 2000;47:242-245.
16. Golbe LI, Davis PH, Schoenberg BS, Duvoisin RC. Prevalence and natural history of progressive supranuclear palsy. Neurology 1988; 38:1031-1034.
17. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9.
18. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
19. Polymeropoulos MH, Higgins JJ, Golbe LI, et al. A gene for Parkinson's disease maps to 4q21-q23. Science 1996;274:1197-1199.
20. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in alpha synuclein identified in families with Parkinson's disease. Science 1997;276:2045-2047.
21. Lazzarini AM, Myers RH, Zimmerman TR, et al. A clinical genetic study of Parkinson's disease: evidence for dominant transmission. Neurology 1994;44:499-506.
22. Piccini P, Burn DJ, Caravolo R, Maraganore D, Brooks DJ. The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins. Ann Neurol 1999;45:577-582.